Essential Pharma
VC Fund
Tokyo, Japan
Essential Pharma is a VC fund in Tokyo focused on Medical and Biotechnology. Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Essential Pharma invests in
Stages Essential Pharma invests in
Countries Essential Pharma invests in
Round sizes
Round size
- Series A
- $2.4M–$4.9M
Investment Focus
Industry
- Medical 3 (75%)
- Biotechnology 2 (50%)
- Pharmaceutical 2 (50%)
- Genetics 1 (25%)
- Oncology 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
- Venture - Series Unknown 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus iscomprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms. | $25.5M / Series B / May 13, 2020 | ||
| HekaBio is a healthcare development, investment, and commercialization platform with experience in oncology, radiation, and cardiovascular therapies. They invest in innovations in oncology, radiation, and cardiovascular therapy and commercialization. HekaBio enables patients by accelerating access to global healthcare innovations. | $4.9M / Series A / Dec 07, 2018 | ||
| HACARUS is a provider of Explainable Lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus' proprietary AI engine is built using Sparse Modeling, anAI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning. | $2.4M / Series A / Oct 05, 2018 | ||
| Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS). | $1.6M / Venture - Series Unknown / Feb 21, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Essential Pharma invest in?
Essential Pharma invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Essential Pharma's check size?
Essential Pharma typically joins rounds of $2.4M–$4.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Essential Pharma participates in.
When did Essential Pharma last invest?
The most recent investment recorded for Essential Pharma closed in May 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
